The federal government has secured orders to buy COVID-19 antiviral medication from pharmaceutical companies Merck and Pfizer. Abigail Bimman reports on the deal, the new national recommendations on who should get a third vaccine dose, and the lingering questions about travel measures.
- Pfizer’s antiviral COVID-19 pill approved by U.K. regulators
- Pfizer’s COVID-19 pill appears effective against Omicron variant, company says
- Canada secures orders of Merck, Pfizer COVID-19 antiviral pills